Company Norda ASA Oslo Bors
Equities
NORD
NO0010285190
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frode Westvold
CEO | Chief Executive Officer | - | 13-04-07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 13-06-19 | |
Chairman | 52 | 12-06-20 | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,148,808 | 322,428 ( 6.262 %) | 178,077 ( 3.459 %) | 6.262 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
NYKODE THERAPEUTICS 2.45% | 7,996,755 | 2.45% | 11,110,292 $ |
DEEP VALUE DRILLER 1.66% | 1,435,284 | 1.66% | 3,525,273 $ |
SAGA PURE ASA 0.45% | 2,185,611 | 0.45% | 259,301 $ |
BERGENBIO ASA 0.17% | 4,529,064 | 0.17% | 81,433 $ |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-18.16% | 11.03B | |
+58.43% | 3.5B | |
-31.31% | 2.23B | |
-14.31% | 2.16B | |
-26.61% | 1.54B | |
+34.35% | 1.12B | |
-3.28% | 737M | |
-22.75% | 477M | |
-40.20% | 411M |